Mexico Hiv Clinical Trials Market Size & Outlook
Related Markets
Mexico hiv clinical trials market highlights
- The Mexico hiv clinical trials market generated a revenue of USD 5.8 million in 2024 and is expected to reach USD 8.2 million by 2030.
- The Mexico market is expected to grow at a CAGR of 6.6% from 2025 to 2030.
- In terms of segment, phase iii was the largest revenue generating phase in 2024.
- Phase I is the most lucrative phase segment registering the fastest growth during the forecast period.
Hiv clinical trials market data book summary
| Market revenue in 2024 | USD 5.8 million |
| Market revenue in 2030 | USD 8.2 million |
| Growth rate | 6.6% (CAGR from 2025 to 2030) |
| Largest segment | Phase iii |
| Fastest growing segment | Phase I |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Phase I, Phase II, Phase III, Phase IV |
Other key industry trends
- In terms of revenue, Mexico accounted for 0.4% of the global hiv clinical trials market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. hiv clinical trials market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in North America and is projected to reach USD 8.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
HIV Clinical Trials Market Scope
HIV Clinical Trials Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Bionor Holding | View profile | 1-10 | Oslo, Oslo, Norway, Europe | https://bionorholding.com |
| SGS SA | View profile | - | - | - |
| Janssen | View profile | 10001+ | Beerse, Antwerpen, Belgium, Europe | https://www.janssen.com/ |
| Parexel International Corporation | View profile | - | - | - |
| Gilead Sciences, Inc. | View profile | - | - | - |
| IQVIA Inc. | View profile | - | - | - |
| PPD | View profile | 11-50 | Tunbridge Wells, Kent, United Kingdom, Europe | https://ppdukltd.com/ |
| Syneos Health | View profile | 1001-5000 | Morrisville, North Carolina, United States, North America | https://www.syneoshealth.com/ |
| Wuxi AppTec Co Ltd | View profile | 41116 | 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, China, People's Republic of, 200131 | https://www.wuxiapptec.com |
| Icon PLC | View profile | 41150 | South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 | https://www.iconplc.com |
| GSK PLC | View profile | 70200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | https://www.gsk.com |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
Mexico hiv clinical trials market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hiv clinical trials market will help companies and investors design strategic landscapes.
Phase iii was the largest segment with a revenue share of 46.55% in 2024. Horizon Databook has segmented the Mexico hiv clinical trials market based on phase i, phase ii, phase iii, phase iv covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Mexico hiv clinical trials market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Mexico hiv clinical trials market databook
-
Our clientele includes a mix of hiv clinical trials market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico hiv clinical trials market , including forecasts for subscribers. This country databook contains high-level insights into Mexico hiv clinical trials market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Mexico Phase - Hiv Clinical Trials Market size, 2024 - 2030 (US$M)
Mexico HIV Clinical Trials Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
